Fitzpatrick, J.-M.; Hackett, B.; Costelloe, L.; Hind, W.; Downer, E.J.
Botanically-Derived Δ9-Tetrahydrocannabinol and Cannabidiol, and Their 1:1 Combination, Modulate Toll-like Receptor 3 and 4 Signalling in Immune Cells from People with Multiple Sclerosis. Molecules 2022, 27, 1763.
https://doi.org/10.3390/molecules27061763
AMA Style
Fitzpatrick J-M, Hackett B, Costelloe L, Hind W, Downer EJ.
Botanically-Derived Δ9-Tetrahydrocannabinol and Cannabidiol, and Their 1:1 Combination, Modulate Toll-like Receptor 3 and 4 Signalling in Immune Cells from People with Multiple Sclerosis. Molecules. 2022; 27(6):1763.
https://doi.org/10.3390/molecules27061763
Chicago/Turabian Style
Fitzpatrick, John-Mark, Becky Hackett, Lisa Costelloe, William Hind, and Eric J. Downer.
2022. "Botanically-Derived Δ9-Tetrahydrocannabinol and Cannabidiol, and Their 1:1 Combination, Modulate Toll-like Receptor 3 and 4 Signalling in Immune Cells from People with Multiple Sclerosis" Molecules 27, no. 6: 1763.
https://doi.org/10.3390/molecules27061763
APA Style
Fitzpatrick, J.-M., Hackett, B., Costelloe, L., Hind, W., & Downer, E. J.
(2022). Botanically-Derived Δ9-Tetrahydrocannabinol and Cannabidiol, and Their 1:1 Combination, Modulate Toll-like Receptor 3 and 4 Signalling in Immune Cells from People with Multiple Sclerosis. Molecules, 27(6), 1763.
https://doi.org/10.3390/molecules27061763
